Skip to main content

Advertisement

Log in

Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations

  • Original Paper
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Oncogenic human papillomaviruses (HPVs) are associated with oropharyngeal squamous cell carcinoma (SCC). Infection with human immunodeficiency virus (HIV) increases susceptibility to opportunistic infections and viral-promoted cancers. The prevalences of HPV, herpes simplex virus (HSV), Epstein-Barr virus (EBV), and human herpesvirus-8 (HHV-8) have not been established for head and neck squamous cell carcinoma in HIV-positive patients (HIV+ HNSCC). We have observed that HIV+ HNSCC tend to contain numerous multinucleated tumor giant cells, this finding has not been described previously. The goal of this study is to test for these oncogenic viruses in a small cohort of retrospectively identified patients with HIV infection, and to compare histologically these cancers to a control group of HNSCC patients. Tumors were reviewed histologically and compared to a control group of 102 patients with HNSCC (serologically untyped or HIV negative). Polymerase chain reaction (PCR) was performed on formalin-fixed, paraffin-embedded HIV+ HNSCC samples from combined 25 patients in two institutions. In situ hybridization was performed to identify EBV (EBER) and immunohistochemistry was performed to detect HSV-1, HSV-2, HHV-8, and HIV-related proteins (Nef, p24). The study sample consisted of 34 HIV+ patients with HNSCC from Montefiore Medical Center, and six HIV+ HNSCC patients from Hospital Clinic, University of Barcelona; 24 (60%) men and 16 (40%) women. The larynx was most commonly involved (65%, n = 26); followed by the oropharynx (22.5%, n = 9). Four carcinomas arose from the oral cavity (10%) and one from the nasal cavity (2.5%). Histologically, multinucleated tumor giant cells were more common in the HIV+ group (39/40, 97.5%) than the control group (27/102, 26%, p 0.001, chi-square). HPV was detected in 6 of 25 (24%) HNSCC tumors by PCR, five were typed as HPV 16 and one as HPV 26/69; five of these tumors (83%) were located in the oropharynx. EBV, HSV-1, HSV-2, and HHV-8 were detected only infrequently in tumor cells. Nef protein was detected in tumor cells in 7 of 21 (33.3%) cases; p24 was not detectable in 6 tumors studied. There were no significant associations between HPV positive tumors and co-infections with other viruses. This study is consistent with other reports that suggest an increased incidence of laryngeal carcinoma for HIV+ patients. HPV was detected in 24% of HIV+ HNSCC, however, the number of tumors with amplifiable DNA (n = 25) is too small to allow for conclusions. EBV, HSV-1, HSV-2, and HHV-8 are uncommon in HIV+ HNSCC; it is unlikely that these viruses have a promoting effect. MNTCG are significantly common in HIV+ HNSCC, but there is overlap in MNTCG counts with the control group and therefore this finding cannot be used as a biomarker of HIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Argiris A, Karamouzis MV, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695–709.

    Article  CAS  PubMed  Google Scholar 

  3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.

    Article  PubMed  Google Scholar 

  4. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001;345:1890–900.

    Article  CAS  PubMed  Google Scholar 

  5. Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer. 2004;108:741–9.

    Article  CAS  PubMed  Google Scholar 

  6. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.

    Article  CAS  PubMed  Google Scholar 

  7. Van Houten VMM, Snijders PJF, van den Brekel MWM, et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer. 2001;93:232–5.

    Article  PubMed  Google Scholar 

  8. Gillison ML, Shah KV. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol. 2001;13:183–8.

    Article  CAS  PubMed  Google Scholar 

  9. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736–45.

    Article  CAS  PubMed  Google Scholar 

  10. Haigentz M Jr. Aerodigestive cancers in HIV infection. Curr Opin Oncol. 2005;17:474–8.

    Article  PubMed  Google Scholar 

  11. Klussman JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001;92:2875–84.

    Article  Google Scholar 

  12. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–83.

    PubMed  Google Scholar 

  13. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96:449–55.

    PubMed  Google Scholar 

  14. Ernster JA, Sciotto CG, O’Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007;117:2115–28.

    Article  PubMed  Google Scholar 

  15. Hobbs CGL, Sterne JAC, Bailey M, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;310:259–66.

    Article  Google Scholar 

  16. D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.

    Article  PubMed  Google Scholar 

  17. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003;104:336–44.

    Article  CAS  PubMed  Google Scholar 

  18. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463–70.

    Article  PubMed  Google Scholar 

  19. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–75.

    Article  CAS  PubMed  Google Scholar 

  20. zur Hausen H. Viruses in human cancers. Science. 1991;254:1167–73.

    Article  CAS  PubMed  Google Scholar 

  21. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–9.

    Article  CAS  PubMed  Google Scholar 

  22. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621–32.

    Article  CAS  PubMed  Google Scholar 

  23. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. NEJM. 2003;348:518–27.

    Article  PubMed  Google Scholar 

  24. zur Hausen H. Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol. 1999;9:405–11.

    Article  CAS  PubMed  Google Scholar 

  25. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690–8.

    Article  CAS  PubMed  Google Scholar 

  26. Hagensee ME, Cameron JE, Leigh JE, Clark RA. Human papillomavirus infection and disease in HIV-infected individuals. Am J Med Sci. 2004;328:57–63.

    Article  PubMed  Google Scholar 

  27. Fakhry C, D’Souza G, Sugar E, et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol. 2006;44:4479–85.

    Article  PubMed  Google Scholar 

  28. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst. 2003;95:1062–71.

    Article  PubMed  Google Scholar 

  29. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97:577–86.

    Article  PubMed  Google Scholar 

  30. Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004;189:686–98.

    Article  PubMed  Google Scholar 

  31. Naher H, Gissmann L, von Knebel Doeberitz C, et al. Detection of Epstein-Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients. J Invest Dermatol. 1991;97:421–4.

    Article  CAS  PubMed  Google Scholar 

  32. Sandvej K, Krenacs L, Hamilton-Dutoit SJ, et al. Epstein-Barr virus latent and replicative gene expression in oral hairy leukoplakia. Histopathology. 1992;20:387–95.

    Article  CAS  PubMed  Google Scholar 

  33. Martel-Renoir D, Grunewald V, Touitou R, et al. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol. 1995;76:1401–8.

    Article  CAS  PubMed  Google Scholar 

  34. Shimakage M, Horii K, Tempaku A, et al. Association of Epstein-Barr virus with oral cancers. Hum Pathol. 2002;33:608–14.

    Article  CAS  PubMed  Google Scholar 

  35. Wong M, Pagano JS, Schiller JT, et al. New Associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst. 2002;94:1832–6.

    CAS  PubMed  Google Scholar 

  36. Jiang G, Qu W, Ruan H, Burk RD. Elimination of false positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. Biotechniques. 1995;19:566–8.

    CAS  PubMed  Google Scholar 

  37. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol. 1997;35:1304–10.

    CAS  PubMed  Google Scholar 

  38. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92:464–74.

    Article  CAS  PubMed  Google Scholar 

  39. Castle PE, Schiffman M, Gravitt P, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002;68:417–23.

    Article  CAS  PubMed  Google Scholar 

  40. Flaitz CM, Nichols CM, Adler-Storthz K, Hicks MJ. Intraoral squamous cell carcinoma in human immunodeficiency virus infection. A clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:55–62.

    Article  CAS  PubMed  Google Scholar 

  41. Singh B, Balwally AN, Shaha AR, et al. Upper aerodigestive tract squamous cell carcinoma. The human immunodeficiency virus connection. Arch Otolaryngol Head Neck Surg. 1996;122:639–43.

    CAS  PubMed  Google Scholar 

  42. Roland JT, Rothstein SG, Mittal KR, Persky MS. Squamous cell carcinoma in HIV-positive patients under age 45. Laryngoscope. 1993;103:509–11.

    PubMed  Google Scholar 

  43. Blenke EJSM, Clement WA, Andrews JM, et al. Squamous cell carcinoma of the larynx in HIV-positive patients: difficulties in diagnosis and management. Dysphagia. 2007;22:68–72.

    Article  CAS  PubMed  Google Scholar 

  44. Moyano S, Ordi J, Caballero M, et al. Laryngeal squamous cell carcinoma in HIV-positive patients: lack of association with human papillomavirus infection. HIV Medicine. 2009. doi:10.1111/j.1468-1293.2009.00737.x.

  45. Gallagher B, Wang Z, Schymura MJ, et al. Cancer incidence in New York State acquired immunodeficiency syndrome. Am J Epidemiol. 2001;154:544–56.

    Article  CAS  PubMed  Google Scholar 

  46. Demopoulos BP, Vamvaka E, Ehrlich JE, et al. Non-acquired immunodeficiency syndrome-defining malignancies in patients infected with human immunodeficiency virus. Arch Pathol Lab Med. 2003;127:589–92.

    PubMed  Google Scholar 

  47. Chaturvedi AK, Madeleine MM, Biggar RJ, Engles EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101:1120–30.

    Article  PubMed  Google Scholar 

  48. Qureshi MN, Barr CE, Seshamma T, et al. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive patients. J Infect Dis. 1995;171:190–3.

    CAS  PubMed  Google Scholar 

  49. Qureshi MN, Barr CE, Hewlitt I, et al. Detection of HIV in oral mucosal cells. Oral Dis. 1997;3(Suppl 1):S73–8.

    PubMed  Google Scholar 

  50. Cox M, Maitland N, Scully C. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa. Eur J Cancer B Oral Oncol. 1993;29B:215–9.

    Article  CAS  PubMed  Google Scholar 

  51. Rassekh CH, Rady PL, Arany I, et al. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope. 1998;108:362–7.

    Article  CAS  PubMed  Google Scholar 

  52. Tyan YS, Liu ST, Ong WR, et al. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors. J Clin Microbiol. 1993;31:53–6.

    CAS  PubMed  Google Scholar 

  53. Pou AM, Vrabec JT, Jordan J, et al. Prevalence of herpes simplex virus in malignant laryngeal lesions. Laryngoscope. 2000;110:194–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Dr. Robert D. Burk, MD, Departments of Microbiology & Immunology, Obstetrics, Gynecology, & Women’s Health at Albert Einstein College of Medicine, Bronx, NY for performing the HPV PCR studies, and Nicolas F. Schlecht, PhD, Department of Epidemiology & Population Health, and Michael B. Prystowsky, MD, PhD, Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, for critical review of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Margaret Brandwein-Gensler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLemore, M.S., Haigentz, M., Smith, R.V. et al. Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations. Head and Neck Pathol 4, 97–105 (2010). https://doi.org/10.1007/s12105-010-0171-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-010-0171-9

Keywords

Navigation